These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17636603)

  • 1. WITHDRAWN: Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000150. PubMed ID: 17636603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2000; 1996(2):CD000150. PubMed ID: 10796496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000151. PubMed ID: 17636604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2000; 1996(2):CD000151. PubMed ID: 10796497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Bromocriptine for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2007 Jul; (4):CD000152. PubMed ID: 17636605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine for idiopathic oligo/asthenospermia.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2000; 1996(2):CD000152. PubMed ID: 10796498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinin-enhancing drugs for unexplained subfertility in men.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 2000; 1996(2):CD000153. PubMed ID: 10796695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Kinin-enhancing drugs for unexplained subfertility in men.
    Vandekerckhove P; Lilford R; Vail A; Hughes E
    Cochrane Database Syst Rev; 1996 Oct; (4):CD000153. PubMed ID: 17636606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants for male subfertility.
    Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
    Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Abou-Setta AM; Al-Inany HG
    Cochrane Database Syst Rev; 2013 Aug; (8):CD005071. PubMed ID: 23970458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia.
    Wang C; Chan CW; Wong KK; Yeung KK
    Fertil Steril; 1983 Sep; 40(3):358-65. PubMed ID: 6411497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men.
    Varma TR; Patel RH
    Int J Gynaecol Obstet; 1988 Feb; 26(1):121-8. PubMed ID: 2892728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia.
    Adamopoulos DA; Pappa A; Billa E; Nicopoulou S; Koukkou E; Michopoulos J
    Fertil Steril; 2003 Oct; 80(4):914-20. PubMed ID: 14556812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Al-Inany HG; Proctor ML
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005071. PubMed ID: 16437514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophins for idiopathic male factor subfertility.
    Attia AM; Al-Inany HG; Farquhar C; Proctor M
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005071. PubMed ID: 17943837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin free beta-subunit in the human seminal plasma: a new marker for spermatogenesis?
    Caroppo E; Niederberger C; Iacovazzi PA; Correale M; Palagiano A; D'Amato G
    Eur J Obstet Gynecol Reprod Biol; 2003 Feb; 106(2):165-9. PubMed ID: 12551786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesterolone and idiopathic male infertility: a double-blind study. World Health Organization Task Force on the Diagnosis and Treatment of Infertility.
    Int J Androl; 1989 Aug; 12(4):254-64. PubMed ID: 2680994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.